TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
HUMA

Humacyte Inc

Healthcare · Biotechnology

0.5856$ +1.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement HUMA
Line item 2019 2020 2021 2022 2023 2024 2025
-75.9% -15.3% +23.9% -100.0%
-28.5% +13.4% -86.5% +827.3% -90.6% +137.1%
-28.5% +13.4% +3.1% +21.0% +15.7% -21.8%
-27.1% +77.3% +8.8% +2.2% +10.3% +20.8%
-26.2% +75.9% +268.6% -69.8% +356.3% -13.8%
-4.2% +97.5% +42.6% +6.4% +40.6% +21.3%
-3,007.0%
-4,045.1%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?